<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03506763</url>
  </required_header>
  <id_info>
    <org_study_id>65409017.0.0000.5327</org_study_id>
    <nct_id>NCT03506763</nct_id>
  </id_info>
  <brief_title>Effect of Pre-medication in Pain Measures on Office Hysteroscopy</brief_title>
  <official_title>Effect of Pre-medication in Pain Measures on Office Hysteroscopy - Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Will be perform a RCT to compare pain measure on office hysteroscopy after pre-medication
      with oral analgesic. Patients will be alocate to oral sodic diclofenac, scopolamin or
      placebo. We will compare visual analog score of pain after the procedure.

      Patients: patients with indication of office hysteroscopy to evaluate uterine intracavitary
      abnormality.

      Interventions Group 1 (control) The patients will receive about 2 h prior to the procedure 2
      placebo tablets.

      Group 2 (diclofenac + scopolamine) The patients will receive about 2 h prior to the procedure
      1 tablet of diclofenac sodium 50 mg and 1 tablet of scopolamine 2 mg.

      Group 3 (diclofenac only). Patients will receive approximately 2 h prior to the procedure 1
      tablet of diclofenac sodium 50 mg and 1 tablet of placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain during and 30 minutes after a hysteroscopy will be measured through the visual analog
      pain scale of 10 centimeters, considering 0 (no pain) and 10 (unbearable pain or the greatest
      pain ever experienced). Acceptance of the procedure and assessed through the Likert 5-point
      scale: 1) totally disagree; 2) disagree; 3) I do not agree or disagree; 4) I agree and 5) I
      totally agree.There will also be a need for analgesia after the procedure, the time spent in
      the observation room and the onset of vagal symptoms such as dizziness, malaise, nausea,
      vomiting or syncope
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>RCT</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>RCT, blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain measure</measure>
    <time_frame>until 1 hour after exam</time_frame>
    <description>Pain Visual analogue score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Likert scale</measure>
    <time_frame>until 1 hour after exam</time_frame>
    <description>Likert scale</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">231</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Placebo Oral + Placebo Oral</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Oral + Placebo Oral</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac oral + Placebo Oral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diclofenac oral + Placebo Oral</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac oral + scopolamina oral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diclofenac oral + scopolamina oral</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral + Placebo Oral</intervention_name>
    <description>Placebo Oral + Placebo Oral</description>
    <arm_group_label>Placebo Oral + Placebo Oral</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac oral + Placebo Oral</intervention_name>
    <description>Diclofenac oral + Placebo Oral</description>
    <arm_group_label>Diclofenac oral + Placebo Oral</arm_group_label>
    <other_name>Diclofenac 50 mg oral tablet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac oral + scopolamina oral</intervention_name>
    <description>Diclofenac oral + scopolamina oral</description>
    <arm_group_label>Diclofenac oral + scopolamina oral</arm_group_label>
    <other_name>Diclofenac 50 mg oral tablet, scopolamin 10 mg oral tablet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. indication of intrauterine evaluation

          2. Abnormal uterine bleeding

          3. post-menopause uterine bleeding

          4. infertility

          5. recurrent miscarriage

        Exclusion Criteria:

          1. stenosis of the external cervical orifice,

          2. pelvic inflammatory disease,

          3. suspected gestation or pregnancy,

          4. active bleeding at the time of examination

          5. contraindication to the use of the study medication, diclofenac sodium and
             scopolamine,
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joao Sabino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HCPA- Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos A Souza, MD</last_name>
    <phone>+5551981189937</phone>
    <email>cbsouza@hcpa.edu.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de Clinicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>90035003</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos A Souza, MD</last_name>
      <phone>+5551981189937</phone>
      <email>souza.cab@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2018</study_first_posted>
  <last_update_submitted>April 13, 2018</last_update_submitted>
  <last_update_submitted_qc>April 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>office hysteroscopy, pain measure</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

